Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
GIP receptor agonism appears to amplify weight loss beyond what GLP-1 alone achieves, which is part of why dual agonists like tirzepatide outperform semaglutide in head-to-head comparisons
Consult with the team at Pure Med Spa Chicago to determine which option best suits your goals
Retatrutide is an investigational triple agonist that targets GIP, GLP-1, and glucagon receptors, while Ozempic is semaglutide, a GLP-1 receptor agonist already approved for type 2 diabetes
PT-141 and Male Sexual Dysfunction Clinical studies have demonstrated that PT-141 can induce a significant erectile response in both healthy males and those with mild-to-moderate ED
It's great to know that you appreciate her attentive listening and educational approach
